• 1
    Parkin DM,Bray F,Ferlay J,Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74108.
  • 2
    IARC. Monographs on the evaluation of carcinogenic risks to humans. vol. 59. Lyon: International Agency for Research on Cancer, 1994.
  • 3
    WHO. Hepatitis B vaccines. Wkly Epidemiol Rec 2004; 79: 263.
  • 4
    WHO and the Viral Hepatitis Prevention Board. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, Antwerp, Belgium. J Viral Hepat 1999; 6: 3547.
  • 5
    Yu MC,Yuan JM,Govindarajan S,Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 2000; 14: 7039.
  • 6
    El-Zayadi AR,Badran HM,Barakat EM,Attia Mel-D,Shawky S,Mohamed MK,Selim O,Saeid A. Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol 2005; 11: 51938.
  • 7
    Hassan MM,Zaghloul AS,El-Serag HB,Soliman O,Patt YZ,Chappell CL,Beasley RP,Hwang LY. The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol 2001; 33: 1236.
  • 8
    Strickland GT,Elhefni H,Salman T,Waked I,Abdel-Hamid M,Mikhail NN,Esmat G,Fix A. Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 2002; 67: 43642.
  • 9
    FreedmanLS,EdwardsBK,RiesLAG,YoungJL, eds. Cancer incidence in four member countries (Cyprus, Egypt, Israel, and Jordan) of the middle east cancer consortium (MECC) compared with US SEER. National Cancer Institute. Bethesda, MD: NIH Pub. No. 06-5873, 2006.
  • 10
    Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988; 61: 194256.
  • 11
    Khella AK,Faris L,Helmy S,Yosif A,Esmail S. Hepatocellular carcinoma; characteristics and possible etiologies in a group of Egyptian patients. J Egypt Public Health Assoc 1992; 67: 74152.
  • 12
    Yates SC,Hafez M,Beld M,Lukashov VV,Hassan Z,Carboni G,Khaled H,McMorrow M,Attia M,Goudsmit J. Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with HCV RNA level. Am J Trop Med Hyg 1999; 60: 71420.
  • 13
    Alavian SM,Fallahian F,Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastointestin Liver Dis 2007; 16: 4036.
  • 14
    Toukan AU. Hepatitis B in the Middle East: aspects of epidemiology and liver disease after infection. Gut 1996; 38 ( Suppl 2): S2S4.
  • 15
    Halim AB,Garry RF,Dash S,Gerber MA. Effect of schistosomiasis and hepatitis on liver disease. Am J Trop Med Hyg 1999; 60: 91520.
  • 16
    Frank C,Mohamed MK,Strickland GT,Lavanchy D,Arthur RR,Magder LS,El Khoby T,Abdel-Wahab Y,Aly Ohn ES,Anwar W,Sallam I. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 88791.
  • 17
    El-Zayadi AR. Curse of schistosomiasis on Egyptian liver. World J Gastroenterol 2004; 10: 107981.
  • 18
    Strickland GT. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 2006; 43: 91522.
  • 19
    Sharara AI,Ramia S,Ramlawi F,Fares JE,Klayme S,Naman R. Genotypes of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other middle Eastern countries. Epidemiol Infect 2007; 135: 42732.
  • 20
    Arafa N,El Hoseiny M,Rekacewicz C,Bakr I,El-Kafrawy S,El Daly M,Aoun S,Marzouk D,Mohamed MK,Fontanet A. Changing pattern of hepatitis C virus spread in rural areas of Egypt. J Hepatol 2005; 43: 41824.
  • 21
    El Gaafary MM,Rekacewicz C,Abdel-Rahman AG,Allam MF,El Hosseiny M,Hamid MA,Colombani F,Sultan Y,El-Aidy S,Fontanet A,Mohamed MK. Surveillance of acute hepatitis C in Cairo, Egypt. J Med Virol 2005; 76: 5205.
  • 22
    WHO. Hepatitis B surface antigen assays: operational characteristics (Phase I). Report 1. Geneva: World Health Organisation, 2001.
  • 23
    WHO. Hepatitis C assays: operational characteristics (Phase II). Report 2. Geneva: World Health Organisation, 2001.
  • 24
    Booth JC,O'Grady J,Neuberger J. Clinical guidelines on the management of hepatitis C. Gut 2001; 49 ( Suppl 1): I1I21.
  • 25
    Central Agency for Public Mobilization and Statistics. Statistical year book. Cairo, Egypt: CAPMAS, 2005.
  • 26
    Reijnders J,Ehrt U,Weber WEJ,Aarsland D,Leentjens AFG. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008; 23: 1839.
  • 27
    Attia MAM,Zekri ARN,Goudsmit J,Boom R,Khaled HM,Mansour MT,de Wolf F,el-Din HM,Sol CJ. Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors. J Clin Microbiol 1996; 34: 26659.
  • 28
    Sherif MM,Abou-Aita BAS,Abou-Elew MH,El-Kafrawi A. Hepatitis B virus infection in upper and lower Egypt. J Med Virol 1985; 15: 12935.
  • 29
    Gumie MAB,Tawfik Ali TM. A sero survey for hepatitis B, syphilis and human immuno deficiency virus antibodies among blood donors and recipients. New Egyp J Med 1990; 4: 9736.
  • 30
    El Sherbini A,Mohsen SA,Seleem Z,Ghany AA,Moneib A,Abaza AH. Hepatitis B virus among schoolchildren in an endemic area in Egypt over a decade: impact of hepatitis B vaccine. Am J Infect Control 2006; 34: 6002.
  • 31
    El Hawey AM,Abdel Hafez MA,Ibrahim MS,Ahmed GN,Hebisha MA. Hepatitis B virus markers in schistosomiasis patients in a village in Menoufia governorate. Egypt, and their response to Praziquantel. New Egypt J Med 1993; 8: 120610.
  • 32
    Arthur RR,Hassan NF,Abdallah MY,El-Sharkawy MS,Saad MD,Hackbart BG,Imam IZ. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt Trans R Soc Trop Med Hyg 1997; 91: 2714.
  • 33
    Mabrouk MA,Abdel-Rahim AY,Zakaria S,El-Garem A. The low frequency of hepatitis B virus infection in schistosomal and non-schistosomal Egyptian army recruits. New Egypt J Med 1994; 10: 22637.
  • 34
    Darwish MA,Raouf TA,Rushdy P,Constantine NT,Rao MR,Edelman R. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 1993; 49: 4407.
  • 35
    Darwish MA,Faris R,Darwish N,Shouman A,Gadallah M,El-Sharkawy MS,Edelman R,Grumbach K,Rao MR,Clemens JD. Hepatitis C and cirrhotic liver disease in the Nile delta of Egypt: a community-based study. Am J Trop Med Hyg 2001; 64: 14753.
  • 36
    Reda AA,Arafa MA,Youssry AA,Wandan EH,Ab de Ati M,Daebees H. Epidemiologic evaluation of the immunity against hepatitis B in Alexandria. Egypt Eur J Epidemiol 2003; 18: 100711.
  • 37
    El Sherbini A,Mohsen SA,Hasan W,Mostafa S,El Gohary K,Moneib A,Abaza AH. The peak impact of an Egyptian outbreak of hepatitis C virus: has it passed or not yet occurred? Liver Int 2007; 27: 8767.
  • 38
    Fathalla SES. Hepatitis C infection among Egyptian blood donors in the eastern Saudi Arabia with/without past history of schistosomiasis. Arch STD HIV Res 1994; 8: 715.
  • 39
    Kumar RM,Frossad PM,Hughes PF. Seroprevalence and mother-to-infant transmission of hepatitis C in asymptomatic Egyptian women. Eur J Obstet Gynecol Reprod Biol 1997; 75: 17782.
  • 40
    Kassem AS,El-Nawawy AA,Massoud MN,Abou El-Nazar SY,Sobhi EM. Prevalence of hepatitis C virus (HCV) infection and its vertical transmission in Egyptian pregnant women and their newborns. J Trop Pediatr 2000; 46: 2313.
  • 41
    Mohamed MK,Magder LS,Abdel-Hamid M,El-Daly M,Mikhail NN,Abdel-Aziz F,Medhat A,Thiers V,Strickland GT. Transmission of hepatitis C virus between parents and children. Am J Trop Med Hyg 2006; 75: 1620.
  • 42
    Stoszek SK,Abdel-Hamid M,Narooz S,El Daly M,Saleh DA,Mikhail N,Kassem E,Hawash Y,El Kafrawy S,Said A,El Batanony M,Shebl FM, et al. Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women. Trans R Soc Trop Med Hyg 2006; 100: 1027.
  • 43
    Abdel-Aziz F,Habib M,Mohamed MK,Abdel-Hamid M,Gamil F,Madkour S,Mikhail NN,Thomas D,Fix AD,Strickland GT,Anwar W,Sallam I. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 2000; 32: 1115.
  • 44
    Nafeh MA,Medhat A,Shehata M,Mikhail NNH,Swifee Y,Abdel-Hamid M,Watts S,Fix AD,Strickland GT,Anwar W,Sallam I. Hepatitis C in a community in upper Egypt: I. Cross-sectional survey. Am J Trop Med Hyg 2000; 63: 23641.
  • 45
    Tanaka Y,Agha S,Saudy N,Kurbanov F,Orito E,Kato T,Abo-Zeid M,Khalaf M,Miyakawa Y,Mizokami M. Exponential spread of hepatitis C virus genotype 4a in Egypt. J Mol Evol 2004; 58: 1915.
  • 46
    Rizk MAH,Osman MI,Gaafar TM,Elawady SAA,Abdel-Hameed O. Hepatitis C virus infection among Egyptian pregnant women and its mother to infant transmission: a prospective study. New Egypt J Med 2002; 27: 16272.
  • 47
    Bakr I,Rekacewicz C,El Hosseiny M,Ismail S,El Daly M,El-Kafrawy S,Esmat G,Hamid MA,Mohamed MK,Fontanet A. Higher clearance of hepatitis C virus infection in females compared with males. Gut 2006; 55: 11837.
  • 48
    Mohamed MK,Bakr I,El-Hoseiny M,Arafa N,Hassan A,Ismail S,Anwar M,Attala M,Rekacewicz C,Zalata K,Abdel-Hamid M,Esmat G, et al. HCV-related morbidity in a rural community of Egypt. J Med Virol 2006; 78: 11859.
  • 49
    Raouf AA,Hosney M,Omer A,El Gammal T,El Sebai H,Zayd IS,Abdel-Sattar L. Hepatitis C virus (HCV) in pregnancy: prevalence and risk factors for infection. Al. Azhar Med J 2004; 33: 23548.
  • 50
    El-Sadawy M,Ragab H,El-Toukhy H,El-Mor AEL,Mangoud AM,Eissa MH,Afefy AF,el-Shorbagy E,Ibrahem IA,Mahrous S,Abdel-Monem A,Sabee EI, et al. Hepatitis C virus infection at Sharkia governorate. Egypt: seroprevalence and associated risk factors. J Egypt Soc Parasitol 2004; 34: 36784.
  • 51
    El-Raziky MS,El-Hawary M,Esmat G,Abouzied AM,El-Koofy N,Mohsen N,Mansour S,Shaheen A,Abdel Hamid M,El-Karaksy H. Prevalence and risk factors of asymptomatic hepatitis C virus infection in Egyptian children. World J Gastroenterol 2007; 13: 182832.
  • 52
    Ahmed L,El-Rooby AS,Rarrag A,Salama Z. Prevalence of hepatitis B virus in patients suffering from primary hepatocellular carcinoma. J Egypt Med Assoc 1986; 69: 36371.
  • 53
    El-Soudani S. Study on the role of schistosomiasis and hepatitis in the development of hepatocellular carcinoma. New Egypt J Med 1993; 8: 16047.
  • 54
    El-Sherif MZ,El-Kannishy MH,Ali AA,Ramadan F,Amra HA. Primary hepatocellular carcinoma and aflatoxicosis. New Egypt J Med 1993; 8: 163340.
  • 55
    Abdel-Wahab MF,Zakaria S,El Kady N,Omar A,Zakaria E,Milad M. Important risk factors related to hepatocellular carcinoma in Egypt. New Egypt J Med 1994; 10: 227681.
  • 56
    Abdel-Wahab M,El-Ghawalby N,Mostafa M,Sultan A,El-Sadany M,Fathy O,Salah T,Ezzat F. Epidemiology of hepatocellular carcinoma in lower Egypt, Mansoura Gastroenterology Center. Hepatogastroenterology 2007; 54: 15762.
  • 57
    Angelico M,Renganathan E,Gandin C,Fathy M,Profili MC,Refai W,De Santis A,Nagi A,Amin G,Capocaccia L,Callea F,Rapicetta M, et al. Chronic liver disease in the Alexandria governorate. Egypt: contribution of schistosomiasis and hepatitis virus infections. J Hepatol 1997; 26: 23643.
  • 58
    Mabrouk GM. Prevalence of hepatitis C infection and schistosomiasis in Egyptian patients with hepatocellular carcinoma. Dis Markers 1997; 13: 17782.
  • 59
    El-Zayadi AR,Abaza H,Shawky S,Mohamed MK,Selim OE,Badran HM. Prevalence and epidemiological features of hepatocellular carcinoma in Egypt—A single center experience. Hepatol Res 2001; 19: 1709.
  • 60
    El-Kafrawy SA,Abdel-Hamid M,El-Daly M,Nada O,Ismail A,Ezzat S,Abdel-Latif S,Abdel-Hamid A,Shields PG,Loffredo C. p53 mutations in hepatocellular carcinoma patients in Egypt. Int J Hyg Environ Health 2005; 208: 26370.
  • 61
    Ezzat S,Abdel-Hamid M,Eissa SA,Mokhtar N,Labib NA,El-Ghorory L,Mikhail NN,Abdel-Hamid A,Hifnawy T,Strickland GT,Loffredo CA. Associations of pesticides. HCV, HBV, and hepatocellular carcinoma in Egypt. Int J Hyg Environ Health 2005; 208: 32939.
  • 62
    Lohiniva AL,Talaat M,Bodenschatz C,Kandeel A,El-Adawy M,Earhart K,Mahoney FJ. Therapeutic injections in the context of Egyptian culture. Promot Educ 2005; 12: 138.
  • 63
    Deuffic-Burban S,Mohamed MK,Larouze B,Carrat F,Valleron AJ. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J Hepatol 2006; 44: 45561.
  • 64
    Lehman EM,Soliman AS,Ismail K,Hablas A,Seifeldin IA,Ramadan M,El-Hamzawy H,Shoushtari CS,Wilson ML. Patterns of hepatocellular carcinoma incidence in Egypt from a population-based cancer registry. Hepatol Res 2008; 38: 46573.
  • 65
    John TJ,Abraham P. Hepatitis B in India: a review of disease epidemiology. Indian Pediatr 2001; 38: 131822.
  • 66
    Batham A,Narula D,Toteja T,Sreenivas V,Puliyel JM. Systematic review and meta analysis of prevalence of hepatitis B in India. Indian Pediatr 2007; 44: 66375.